150 results on '"O'Donnell, James S."'
Search Results
2. Novel functions for Von Willebrand factor
3. Type 1 VWD classification revisited - novel insights from combined analysis of the LoVIC and WiN studies
4. The Nijmegen ultra-sensitive Bethesda Assay detects very low-titer factor VIII inhibitors in patients with congenital and acquired hemophilia A
5. VWF-ADAMTS13 axis dysfunction in children with sickle cell disease treated with hydroxyurea versus blood transfusion
6. Enhanced thrombin generation potential and endothelial dysfunction in chronic spontaneous urticaria
7. Unraveling coagulation factor–mediated cellular signaling
8. GLYCOLYTIC REPROGRAMMING FUELS MYELOID CELL-DRIVEN HYPERCOAGULABILITY
9. Elevated von Willebrand factor levels in multiple myeloma: Dysregulated mechanisms of both secretion and clearance
10. Von Willebrand factor-inflammation crosstalk in deep vein thrombosis
11. Corrigendum to Examining international practices in the management of pregnant women with von Willebrand disease [J Thromb Haemost. 2022 Jan;20(1):82-91]
12. Low von Willebrand Disease: A Bleeding Disorder of Unknown Cause?
13. Endothelial cell activation, Weibel-Palade body secretion, and enhanced angiogenesis in severe COVID-19
14. Enhanced VWF clearance in low VWF pathogenesis: limitations of the VWFpp/VWF:Ag ratio and clinical significance
15. Variability in ISTH-BAT score with normal ageing in healthy females; contributory factors and clinical significance.
16. von Willebrand factor links primary hemostasis to innate immunity
17. Longitudinal bleeding assessment in von Willebrand disease utilizing an interim bleeding score
18. Sustained VWF-ADAMTS-13 axis imbalance and endotheliopathy in long COVID syndrome is related to immune dysfunction
19. Breast cancer cells mediate endothelial cell activation, promoting von Willebrand factor release, tumor adhesion, and transendothelial migration
20. Perspective: The Case for Acute Large Vessel Ischemic Stroke in COVID-19 Originating Within Thrombosed Pulmonary Venules
21. Laboratory assays of VWF activity and use of desmopressin trials in the diagnosis of VWD: a systematic review and meta-analysis
22. Neutrophils in COVID-19: Not Innocent Bystanders
23. von Willebrand disease and von Willebrand factor
24. Hemostatic and protein C pathway dysfunction in the pathogenesis of experimental cerebral malaria
25. Nanoparticle Biomolecular Corona-Based Enrichment of Plasma Glycoproteins for N-Glycan Profiling and Application in Biomarker Discovery
26. Practical treatment guidance for cancer-associated thrombosis – Managing the challenging patient: A consensus statement
27. Therapeutic implications of ongoing alveolar viral replication in COVID-19
28. The von Willebrand factor – ADAMTS‐13 axis in malaria
29. Examining international practices in the management of pregnant women with von Willebrand disease
30. Persistent endotheliopathy in the pathogenesis of long COVID syndrome ‐ Reply to comment from von Meijenfeldt et al.
31. von Willebrand factor levels in the diagnosis of von Willebrand disease: a systematic review and meta-analysis
32. Bleeding assessment tools in the diagnosis of VWD in adults and children: a systematic review and meta-analysis of test accuracy
33. How I treat bleeding disorder of unknown cause
34. Bleeding Outcomes in People with Von Willebrand Disease Receiving Antithrombotic Therapy
35. Current practice and registration patterns among United Kingdom Haemophilia Centre Doctors’ Organisation centers for patients with unclassified bleeding disorders
36. Single centre, real‐world experience of perioperative rFIXFc use in adult patients with haemophilia B undergoing major and minor surgery
37. Recombinant factor IX‐Fc fusion protein in severe hemophilia B: Patient‐reported outcomes and health‐related quality of life
38. Persistent endotheliopathy in the pathogenesis of long COVID syndrome
39. ADAMTS13 regulation of VWF multimer distribution in severe COVID‐19
40. Musculoskeletal ultrasound in hemophilia: Results and recommendations from a global survey and consensus meeting
41. Illustrated State‐of‐the‐Art Capsules of the ISTH 2021 Congress
42. Vaccine‐induced immune thrombotic thrombocytopenia (VITT) – a novel clinico‐pathological entity with heterogeneous clinical presentations
43. The Biological Significance of von Willebrand Factor O-Linked Glycosylation
44. Pulmonary immuno-thrombosis in COVID-19 ARDS pathogenesis
45. Real‐world outcomes with recombinant factor IX Fc fusion protein (rFIXFc) prophylaxis: Longitudinal follow‐up in a national adult cohort
46. Prolonged elevation of D‐dimer levels in convalescent COVID‐19 patients is independent of the acute phase response
47. Sialylation on O-linked glycans protects von Willebrand factor from macrophage galactose lectin-mediated clearance
48. Management of elective procedures in low von Willebrand factor patients in the LoVIC study
49. Toward Personalized Treatment for Patients with Low von Willebrand Factor and Quantitative von Willebrand Disease
50. The immunophilin protein FKBPL and its peptide derivatives are novel regulators of vascular integrity and inflammation via NF-κB signaling
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.